Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 9:372:n579.
doi: 10.1136/bmj.n579.

Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study

Robert Challen  1   2   3 , Ellen Brooks-Pollock  3   4   5 , Jonathan M Read  3   6 , Louise Dyson  3   7 , Krasimira Tsaneva-Atanasova  8   9 , Leon Danon  3   5   9   10
Affiliations

Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study

Robert Challen et al. BMJ. .

Abstract

Objective: To establish whether there is any change in mortality from infection with a new variant of SARS-CoV-2, designated a variant of concern (VOC-202012/1) in December 2020, compared with circulating SARS-CoV-2 variants.

Design: Matched cohort study.

Setting: Community based (pillar 2) covid-19 testing centres in the UK using the TaqPath assay (a proxy measure of VOC-202012/1 infection).

Participants: 54 906 matched pairs of participants who tested positive for SARS-CoV-2 in pillar 2 between 1 October 2020 and 29 January 2021, followed-up until 12 February 2021. Participants were matched on age, sex, ethnicity, index of multiple deprivation, lower tier local authority region, and sample date of positive specimens, and differed only by detectability of the spike protein gene using the TaqPath assay.

Main outcome measure: Death within 28 days of the first positive SARS-CoV-2 test result.

Results: The mortality hazard ratio associated with infection with VOC-202012/1 compared with infection with previously circulating variants was 1.64 (95% confidence interval 1.32 to 2.04) in patients who tested positive for covid-19 in the community. In this comparatively low risk group, this represents an increase in deaths from 2.5 to 4.1 per 1000 detected cases.

Conclusions: The probability that the risk of mortality is increased by infection with VOC-202012/01 is high. If this finding is generalisable to other populations, infection with VOC-202012/1 has the potential to cause substantial additional mortality compared with previously circulating variants. Healthcare capacity planning and national and international control policies are all impacted by this finding, with increased mortality lending weight to the argument that further coordinated and stringent measures are justified to reduce deaths from SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: support from the Engineering and Physical Sciences Research Council, NHS England, Global Digital Exemplar programme, Alan Turing Institute, Medical Research Council, and National Institute for Health Research Health Protection Research Unit in Behavioural Science and Evaluation, in partnership with Public Health England; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.

Figures

Fig 1
Fig 1
Sample selection algorithm showing average figures for numbers of participants in each study arm. Matching involved random sampling to create 50 replicates. Some cases were excluded for more than one reason
Fig 2
Fig 2
Kaplan-Meier survival curve for S gene positive (previously circulating variants) and S gene negative (new variant VOC-202012/1) participants in the UK. The y axis has been truncated as mortality was low in both groups
Fig 3
Fig 3
Investigation of biases in S gene positive and S gene negative study arms
Fig 4
Fig 4
Sensitivity analyses. Red bar indicates default assumptions (cycle threshold <30; age tolerance ±5 years; sample date tolerance ±1 day) from rest of study
See this image and copyright information in PMC

Comment in

References

    1. Wise J. Covid-19: New coronavirus variant is identified in UK. BMJ 2020;371:m4857. 10.1136/bmj.m4857 - DOI - PubMed
    1. Investigation of novel SARS-CoV-2 variant: Variant of Concern 202012/01 - Technical briefing 4. https://assets.publishing.service.gov.uk/government/uploads/system/uploa...
    1. Prime Minister announces Tier 4: ‘Stay At Home’ Alert Level in response to new COVID variant. GOV.UK. www.gov.uk/government/news/prime-minister-announces-tier-4-stay-at-home-... (accessed 30 Jan 2021).
    1. Risk related to the spread of new SARS-CoV-2 variants of concern in the EU/EEA – first update. Eur. Cent. Dis. Prev. Control. 2021. www.ecdc.europa.eu/en/publications-data/covid-19-risk-assessment-spread-... (accessed 30 Jan 2021). - PubMed
    1. CDC. US COVID-19 Cases Caused by Variants. Centers for Disease Control and Prevention. 2020. www.cdc.gov/coronavirus/2019-ncov/transmission/variant-cases.html (accessed 30 Jan 2021).

Publication types